These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6242058)

  • 1. [Immunological studies on renal transplantation. III. Experimental studies on the immunosuppressive action of cyclosporin A].
    Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1857-65. PubMed ID: 6242058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological studies on renal transplantation. IV. Studies on the mode of action of cyclosporin A].
    Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1866-73. PubMed ID: 6242059
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation.
    Keown PA; Stiller CR; Ulan RA; Sinclair NR; Rankin C; Carruthers G; Wall WJ
    Transplant Proc; 1981 Sep; 13(3):1669-72. PubMed ID: 6458135
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin. Mechanism of action: in vitro studies.
    Hess AD; Colombani PM
    Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A--usefulness, risks and mechanism of action.
    Britton S; Palacios R
    Immunol Rev; 1982; 65():5-22. PubMed ID: 6288546
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
    Bunjes D; Hardt C; Röllinghoff M; Wagner H
    Eur J Immunol; 1981 Aug; 11(8):657-61. PubMed ID: 6456149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of in vitro alloreactivity by cyclosporin A: evidence for an inter-individual variation in sensitivity.
    Sander B; Brigati C; Möller E
    Scand J Immunol; 1986 Apr; 23(4):435-40. PubMed ID: 2939552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A.
    Morris PJ
    Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the immunologic and pharmacodynamic effects of cyclosporine following renal transplantation.
    Keown PA; Coles R; Flechner I; Stawecki M; Stiller CR
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):252-6. PubMed ID: 2947367
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune status of transplant recipients immunosuppressed with cyclosporin-A.
    White DJ; Plumb A; Calne RY
    Transplant Proc; 1981 Sep; 13(3):1666-8. PubMed ID: 6458134
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunobiology of cyclosporin A--a review.
    Thomson AW
    Aust J Exp Biol Med Sci; 1983 Apr; 61 (Pt 2)():147-72. PubMed ID: 6349597
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production.
    Manfro RC; Pohanka E; Tomlanovich S; Benet LZ; Garovoy MR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1457-9. PubMed ID: 2523586
    [No Abstract]   [Full Text] [Related]  

  • 18. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of in vitro lymphocyte reactivity by cyclosporin A: existence of a population of drug-resistant cytotoxic lymphocytes.
    Horsburgh T; Wood P; Brent L
    Nature; 1980 Aug; 286(5773):609-11. PubMed ID: 6447256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.